Drugs & medicalClass II

Hikma Pharmaceuticals USA INC recalls Alendronate Sodium Oral Solution, 70 mg/75 mL, 75 mL, Rx only, 4 x 75 mL Single Dose Bottles, Distr. by: Hikma Pharmaceuticals USA…

This recall is being conducted due to out of specification assay results in a limited number of bottles that were stored on side.

Read the official notice →
Date
2026-05-06
Country
United States
Brand
Hikma Pharmaceuticals
Product
Alendronate Sodium Oral Solution, 70 mg/75 mL, 75 mL, Rx only, 4 x 75 mL Single Dose Bottles, Distr. by: Hikma Pharmaceuticals USA Inc.,…
Classification
Class II
Units
US Nationwide.
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Hikma Pharmaceuticals recalls

  1. 2026-09-02
  2. US
    Drugs & medicalClass II

    Hikma Pharmaceuticals USA INC. recalls Ramipril Capsules USP, 10 mg, packaged in a) 100 Capsules (NDC 76282-673-01) and b) 500 Capsules (NDC 76282-673-05) bottles, Rx…

    Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).

    FDA · DrugHikma Pharmaceuticals USA INC.Nationwide within the United StatesOfficial notice →
  3. 2025-08-06
  4. US
    Drugs & medicalClass II

    Hikma Pharmaceuticals USA Inc. recalls Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactured by: Hikma Berkeley Heights, NJ 07922, NDC#…

    Failed Impurities/Degradation Specifications: An out-of-Specification for total related compounds

    FDA · DrugHikma Pharmaceuticals USA Inc.Distributed Nationwide in the USAOfficial notice →
  5. 2024-08-28
  6. US
    Drugs & medicalClass I

    Hikma Pharmaceuticals USA Inc. recalls Acetaminophen Injection, 1,000 mg per 100 mL (10 mg/mL), 100 mL Single Dose bags, For Intravenous Use Only, Rx Only, Manufactured…

    Labeling: Label Mix-up: a bag of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection was found inside an overwrap labeled Acetaminophen Injection 1,000 mg per 100 mL (10 mg/mL)

    FDA · DrugHikma Pharmaceuticals USA Inc.OH and PROfficial notice →
  7. 2024-03-27
  8. US
    Drugs & medicalClass II

    Hikma Pharmaceuticals USA Inc. recalls Infumorph (Preservative-free Morphine Sulfate Sterile Solution), 20 mL ampul, Rx only, Manufactured by Hikma Berkeley Heights, NJ…

    The filter included in the carton has an expiration date that has expired prior to the expiration date of the actual product lot.

    FDA · DrugHikma Pharmaceuticals USA Inc.Nationwide within the United StatesOfficial notice →
  9. 2023-05-24
  10. US
    Drugs & medicalClass II

    Hikma Pharmaceuticals USA Inc. recalls Lorazepam Injection, USP, 2mg/mL, 1 mL vial (NDC 0641-6044-01), packaged in 25 x 1 mL Vials per carton (NDC 0641-6044-25), Rx…

    Failed Impurities/Degradation Specifications: Out-of-specification results for total related compounds observed during retain steting due to the elevated Related Compound-C.

    FDA · DrugHikma Pharmaceuticals USA Inc.Nationwide in the USA and Puerto RicoOfficial notice →
  11. 2023-01-04
  12. US
    Drugs & medicalClass II

    Hikma Pharmaceuticals USA Inc. recalls Ganciclovir for Injection, USP, 500mg per vial, packaged in a 10-count carton, Rx Only, Mfd. by: THYMOORGAN PHARMAZIE GmbH,…

    Labeling: Label mix-up - one vial was mislabeled as Cladribine Injection 10mg/mL inside a 10-count carton of Ganciclovir 500 mg.

    FDA · DrugHikma Pharmaceuticals USA Inc.USA NationwideOfficial notice →
All 8 Hikma Pharmaceuticals recalls →

Other drugs & medical recalls in the United States

  1. 2026-05-06
  2. US
    Drugs & medicalClass II

    Healthmark Industries Co., Inc. recalls Mesh Style Tip Protectors CSW-03-2.0 Open-end style CSW-04-4.0 Closed-end style

    Product does not have FDA clearance.

    FDA · DeviceHealthmark Industries Co., Inc.US Nationwide distribution.Official notice →
  3. US
    Drugs & medicalClass I

    WHILL, INC. recalls WHILL Model C2, with software versions before HMI: 2.22 / MC: 1.13; device is an indoor/outdoor battery-operated 2-wheel drive (rear-wheel…

    Cyber vulnerability of BLE communication was found by CISA VDP program.

    FDA · DeviceWHILL, INC.US: KansasOfficial notice →
  4. US
    Drugs & medicalClass I

    Boston Scientific Corporation recalls Boston Scientific Cardiac Resynchronization Therapy (CRT)labeled as: 1. VALITUDE CRT-P EL, Model Number U125; 2. VALITUDE CRT-P EL…

    Updated software, Brady software maintenance release 6 (SMR6), is now available for the ACCOLADE" family of pacemakers and cardiac resynchronization therapy pacemakers (CRT-Ps)1 and the advisory population is expanding…

    FDA · DeviceBoston Scientific CorporationworldwideOfficial notice →
  5. US
  6. US
  7. US
    Drugs & medicalClass II

    Thea Pharma, Inc. recalls Similasan, iVIZIA, Sterile Lubricant Eye Drops (Povidone 0.5%), 0.33 Fl oz (10 mL), Made in France, Distributed by: Thea Pharma Inc.,…

    Lack of Assurance of Sterility: This recall has been initiated due to CGMP deviations found by the FDA during an inspection of the manufacturer.

    FDA · DrugThea Pharma, Inc.Nationwide within the United StatesOfficial notice →
See all drugs & medical recalls →